Aenova has been awarded the rating "Highest reputation: outstanding" by the german business magazine Focus Money.

The award is based on a study by the Institute for Management and Economic Research (Institut für Management und Wirtschaftsforschung, IMWF), which analyzed the reputation of the 20,000 largest German companies in the areas of management, sustainability, product and service, performance. For this purpose, a total of 20 million reviews - customer ratings, testimonials, comments and more - from the Internet on the tested companies in the period from February 2022 to January 2023 were recorded and evaluated.

Of the 20,000 companies, 1,000 received the "Highest Reputation" seal of approval and Aenova was able to position itself in the pharmaceutical sector alongside major international pharmaceutical companies with the award.

"We are very pleased to receive this award," commented Jan Kengelbach, CEO of Aenova Group. "It reflects very well how the Aenova Group has developed over the last two years in the areas of performance, product, service, management and sustainability. This is a joint success to which every colleague has contributed!"